Seroprevalence survey of rubella infection in pregnancy at the University of Benin Teaching Hospital, Benin City, Nigeria

Nigerian Journal of Clinical Practice

Volumn 14, Issue 2, 2011, Pages 140-145

  Onakewhor, J U ^a   Chiwuzie, J ^a  

^a UNIVERSITY OF BENIN   (Nigeria)

Author keywords

Pregnancy; Rubella; Sero markers; Vaccination

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; FEMALE; HUMAN; IMMUNOLOGY; MIDDLE AGED; NIGERIA; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL CARE; PREVALENCE; PROSPECTIVE STUDY; RUBELLA; RUBELLA VIRUS; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MIDDLE AGED; NIGERIA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PREVALENCE; PROSPECTIVE STUDIES; RUBELLA; RUBELLA VIRUS; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 80052430260     PISSN: 11193077     EISSN: None     Source Type: Journal    
DOI: 10.4103/1119-3077.84002     Document Type: Article

References (36)

1. World Health Organization. World Health Organization Report on Infectious Diseases: Removing Obstacles to Healthy Development. WHO Report on Infectious Diseases, 1999. http://www. who.int [last Accessed on 2011 Jan 17].
2. World Health Organization. Rubella vaccines: WHO position paper; Wkly Epidemiol Rec 2000,75:161-9.
3. Coulter C, Wood R, Robson J. Rubella infection in Pregnancy. Commun Dis Intell 1999;23:93-6.
4. Mehta NM, Thomas RM. Antenatal screening for rubella-infection or immunity? BMJ. 2002;325:90-1. (Pubitemid 34774884)
5. Onakewhor JU, Okonofua FE. The Prevalence of Dual Human Immunodeficiency Virus/Hepatitis C Virus (HIV/HCV) Infection in Asymptomatic Pregnant Women in Benin City, Nigeria. Afr J Reprod Health 2009;13:97-108.
6. Centers for Disease Control and Prevention. Rubella Outbreak - Arkansas, 1999 Report. Editorial Note. MMWR Morb Mort Wkly Rep 2001;50:1137-9.
7. Bar-Oz B, Ford-Jones L, Koren G. Congenital rubella syndrome: How can we do better? Can Fam Physician 1999;45:1865-7.
8. Gross M, Finckh-Kramer U, Spormann-Lagodzinski M. Congenital hearing disorders in children. 1: Acquired hearing disorders. HNO 2000;48:879-86. (Pubitemid 32038818)
9. Sadighi J, Eftekhar H, Mohammad K. Congenital rubella syndrome in Iran. BMC Infect Dis 2005;5:44.
10. Rahman MM, Khan AM, Hafiz MM, Ronny FM, Ara S, Chowdhury SK, et al. Congenital hearing impairment associated with rubella: Lessons from Bangladesh. Southeast Asian J Trop Med Public Health 2002;33:811-7.
11. Morice A, Ulloa-Gutierrez R, Ávila-Agüero ML. Congenital Rubella Syndrome: Progress and Future Challenges. Expert Rev Vaccines 2009;8:323-31.
12. Orenstein WA, Bart KJ, Hinman AR, Preblud SR, Greaves WL, Doster SW, et al. The opportunity and obligation to eliminate rubella from the United States. JAMA 1984;251:1988-94 (Pubitemid 14172240)
13. Bamgboye AE, Afolabi KA, Esumeh FI, Enweani IB. Prevalence of rubella antibody in pregnant women in Ibadan, Nigeria. West African J Med 2004;23:245-8. (Pubitemid 39530283)
14. Reddy M, Bindu HL, Reddy PP, Rani UP. Role of intrauterine Rubella infection in the causation of congenital deafness. Indian J Hum Genet 2006;12:140-3. (Pubitemid 46183411)
15. Centers for Disease Control and Prevention: Nationwide campaign for vaccination of adults against rubella and measles Costa Rica 2001. MMWR Morb Mort Wkly Rep 2001;150:976-9.
16. Morice A, Carvajal X, León M, Machado M, Badilla X, Reef S, et al. Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: The Costa Rican experience. J Infect Dis 2003;187:158-63.
17. Centers for Disease Control and Prevention. Progress toward elimination of rubella and congenital rubella syndrome - the Americas, 2003-2008. MMWR Morb Mort Wkly Rep 2008;57:1176-9.
18. Kelly H, Worth L, Karapanagiotidis T, Riddell M. Interruption of rubella virus transmission in Australia may require vaccination of adults males: Evidence from a Victorian sero-survey. Commun Dis Intel 2004;28,69-73.
19. Castillo-Solorzano C, Carrasco P, Tambini G, Reef S, Brana M, de Quadros CA. New horizons in the control of rubella and prevention of congenital rubella syndrome in the Americas. J Infect Dis 2003;187: S146-52 (Pubitemid 36583947)
20. Onyenekwe CC, Kehinde-Agbeyangi TA, Ofor US, Arinola OG. Prevalence of rubella-IgG antibody in women of childbearing age in Lagos, Nigeria. West Afr J Med 2000;19:23-6.
21. Pennap G, Amauche G, Ajoge H, Gabadi S, Agwale S, Forbi J. Serologic Survey of Specific Rubella Virus IgM in the Sera of Pregnant Women in Makurdi, Benue State, Nigeria. Afr J Reprod Health 2009;13:69-73.
22. Bukbuk DN, el Nafaty AU, Obed JY. Prevalence of rubella-specific IgG antibody in non-immunized pregnant women in Maiduguri, north eastern Nigeria. Cent Eur J Public Health 2002;10:21-3. (Pubitemid 34663948)
23. Dia Pro. Diagnostic Bioprobes SrI. Rubella IgG and IgM kits manufacturing company, 'Insert.' Dia Pro. Diagnostic Bioprobes SrI. Available from: http://www.diapro@tin. it [Last accessed on 2003].
24. Sallam TA, Raja'a YA, Benbrake MS, Al-Shaibani KS, Al-Hababi AA. Prevalence of rubella antibodies among schoolgirls in Sana'a, Republic of Yemen. East Mediterr Health J 2003;9:148-51. (Pubitemid 40520572)
25. National Millennium Development Goals Report-Nigeria 2004. Goal 3: Promote gender equality and empower women. National Millennium Development Goals Report-Nigeria 2004;22-31.
26. Federal Ministry of Health National(FMOH)-National AIDS and STI Control Programme(NASCP)- Nigeria National Health Sector Strategic Plan for HIV and AIDS in Nigeria 2005-2009-Targeting Service for the most- at-risk populations. FMOH -NASCP. Abuja, Nigeria; 2006. p. 16.
27. Morice A, Ulloa-Gutierrez R, Avila-Agüero ML. Congenital Rubella Syn- drome: Progress and Future Challenges. Expert Rev Vaccines 2009;8:323-31.
28. Castillo-Solórzano de Quadros CE. Accelerated rubella control and the prevention of congenital rubella syndrome. Rev Panam Salud Publica 2002;11:273-6.
29. Panagiotopoulos T, Antoniadou I, Valassi-Adam E. Increase in congenital rubella occurrence after immunization in Greece: Retrospective survey and systematic review. BMJ 1999;319:1462-5.
30. Terada K. Rubella and congenital rubella syndrome in Japan: Epidemiological problems. Jpn J Infect Dis 2003;56,81-7. (Pubitemid 37161784)
31. Centers for Disease Control and Prevention: Measles, mumps and rubella vaccine use and strategies for elimination of measles, rubella and congenital rubella syndrome and control of mumps. Recommendation of the Advisory Committee on Immunization Practices. MMWR Morb Mort Wkly 1998;47:1?57.
32. Nasiri R, Yoseffi J, Khajedaloe M, Sarafraz YM, Delgoshaei F. Congenital rubella syndrome after rubella vaccination in 1-4 weeks periconceptional period. Indian J Pediatr 2009;76:279-82.
33. Bar- Oz B, Levicheck Z, Moretti ME, Mah C, Andreou C Koren G. Pregnancy outcome following rubella vaccination: A prospective controlled study. Am J Clin Genetics A 2004;130:52-4. (Pubitemid 39121561)
34. Centers for Disease Control and Prevention: Revised ACIP recommendation for avoiding pregnancy after reviewing a rubella-containing vaccine. MMWR Morb Mort Wkly Rep 2001;50:1117.
35. Newton V. Adverse perinatal conditions and the inner ear. Semin Neonatol 2001;6:543-51. (Pubitemid 34670097)
36. Onakewhor JU, Gharoro EP "Changing Trends in Maternal mortality in a developing country." Niger J Clin Pract 2008;11:111-20.